Advertisement

Topics

Dura Pharmaceuticals Company Profile

02:54 EST 25th November 2017 | BioPortfolio

Developer and marketer of prescription pharmaceutical products for the treatment of allergies, asthma and related respiratory conditions.


News Articles [454 Associated News Articles listed on BioPortfolio]

Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals

Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery technology.

Salix Pharmaceuticals (SLXP) vs. Its Rivals Head to Head Survey

Salix Pharmaceuticals is one of 19 public companies in the "Specialty & Advanced Pharmaceuticals" industry, but how does it contrast to its rivals? We will compare Salix Pharmaceuticals to related...

Financial Contrast: Arena Pharmaceuticals

Arena Pharmaceuticals and Sunesis Pharmaceuticals are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst re...

Inotek Pharmaceuticals announces merger deal with Rocket Pharmaceuticals

Inotek Pharmaceuticals announced that it has entered into a definitive merger agreement with US-based gene therapy company Rocket Pharmaceuticals.

Contrasting Pacira Pharmaceuticals

Pacira Pharmaceuticals and Lannett Co are both small-cap pharmaceuticals - nec companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings...

Easton Pharmaceuticals Announces That Its Partner Windsor Pharmaceuticals Has Received Regulatory Approvals For Products VS-Sense and AL-Sense For Central America and The Caribbean

TORONTO, ON -- (Marketwired) -- 09/12/17 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) and its JV partner BMV Medica SA de CV announces that its distributor Windsor Pharmaceuticals SA has receiv...

Cerecor to acquire TRx Pharmaceuticals

Cerecor has entered into an agreement to TRx Pharmaceuticals and its subsidiary Zylera Pharmaceuticals.

Imprimis launches Surface Pharmaceuticals subsidiary

Imprimis Pharmaceuticals, an ophthalmology-focused pharmaceutical company, has filed a Form 8-K with the SEC which contains a corporate presentation for its subsidiary, Surface Pharmaceuticals. Surf...

PubMed Articles [151 Associated PubMed Articles listed on BioPortfolio]

Negative Pressure Wound Therapy to the Dura.

Negative-pressure wound therapy is historically contraindicated in patients with osteomyelitis or exposed dura. The authors present a case of a complex reconstruction of an infected full thickness sca...

Quantifying Macrophages and Hemosiderin in Pediatric Dura Mater.

Determining the age of a subdural hematoma at autopsy is of great interest for medicolegal purposes. The appearance of pigment-laden macrophages is often referenced as evidence that the subdural hemat...

Rectus Capitis Posterior Minor: Histological and Biomechanical Links to the Spinal Dura Mater.

Serial histological investigation was performed on 10 cadaveric specimens and biomechanical tests were performed on five specimens, both focused on the tissue connexion between the rectus capitis post...

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Clinical Trials [225 Associated Clinical Trials listed on BioPortfolio]

Study of SyntheCelTM Dura Replacement to Other Dura Replacements

Primary Objective: To demonstrate that the SyntheCelTM Dura Replacement performs similarly to or is substantially equivalent to other dura replacements for the repair of the cranial dura i...

SyntheCel Dura Replacement in Patients Requiring Dura Repair

The objective of the clinical investigation is to demonstrate that the SyntheCelTM Dura Replacement is substantially equivalent to other dura replacements cleared for marketing by the FDA ...

Fibrin Sealant for the Sealing of Dura Sutures

The purpose of this study is to investigate the efficacy and safety of FS VH S/D 500 s-apr, a double virus-inactivated biological two-component fibrin sealant, for use in posterior fossa s...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [1290 Associated Companies listed on BioPortfolio]

Dura Pharmaceuticals Incorporated

Dura Pharmaceuticals are a specialty respiratory pharmaceutical and pulmonary drug delivery company. Dura Pharmaceuticals are engaged in developing and marketing prescription pharmaceutical products f...

Dura Pharmaceuticals

Developer and marketer of prescription pharmaceutical products for the treatment of allergies, asthma and related respiratory conditions.

Elevation Pharmaceuticals, Inc.

Elevation Pharmaceuticals is a biopharmaceutical company focused on developing new inhaled therapies for patients with respiratory disease. The Company was founded in 2008 by Cam Garner, formerly Cha...

TEI Biosciences Inc.

A Boston-based, privately-held, leading biomedical company, TEI Biosciences Inc. has applied its expertise in regenerative medicine to develop and commercialize novel biologic products for a broad spe...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

More Information about "Dura Pharmaceuticals" on BioPortfolio

We have published hundreds of Dura Pharmaceuticals news stories on BioPortfolio along with dozens of Dura Pharmaceuticals Clinical Trials and PubMed Articles about Dura Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dura Pharmaceuticals Companies in our database. You can also find out about relevant Dura Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...


Corporate Database Quicklinks



Searches Linking to this Company Record